Neuronetics, Inc.
Neuronetics, Inc. (STIM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
stim · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Neuronetics, Inc. (STIM) measures how much investors pay for each dollar of the company's trailing earnings. STIM's current PE ratio of N/A is calculated by dividing its stock price of $1.28 by its TTM earnings per share of -$0.53.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2016 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Neuronetics, Inc.You STIM | $89M | N/A | — | -$0.53 |
 Atlantic International Corp. ATLN | $61M | N/A | — | -$1.08 |
 Perspective Therapeutics, Inc. CATX | $226M | N/A | — | -$1.40 |
 Codexis, Inc. CDXS | $237M | N/A | — | -$0.50 |
 Genfit S.A. GNFT | $446M | 119.75x | — | $0.03 |
 Nyxoah S.A. NYXH | $52M | N/A | — | -$2.36 |
 OmniAb, Inc. OABI | $272M | N/A | — | -$0.57 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.59 | — | |
2024-12-31 FY2024 | — | $-1.38 | — | |
2023-12-31 FY2023 | — | $-1.05 | — | |
2022-12-31 FY2022 | — | $-1.38 | — | |
2021-12-31 FY2021 | — | $-1.22 | — | |
2020-12-31 FY2020 | — | $-1.46 | — | |
2019-12-31 FY2019 | — | $-1.58 | — | |
2018-12-31 FY2018 | — | $-2.69 | — | |
2017-12-31 FY2017 | — | $-1431.28 | — | |
2016-12-31 FY2016 | — | $-1001.25 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Neuronetics, Inc. (STIM) measures how much investors pay for each dollar of the company's trailing earnings. STIM's current PE ratio of N/A is calculated by dividing its stock price of $1.28 by its TTM earnings per share of -$0.53.
Frequently asked questions
STIM pe ratio · 6 questionsSTIM's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.28 and TTM EPS of -$0.53. Data sourced from Financial Modeling Prep via STIM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Neuronetics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09